Table 1. Characteristics of postpartum HIV-infected mothers.

	n	% or median (IQR)
Total	3153
Geographical Region
North/central rural	785	24.9
North/central urban	828	26.3
South rural	868	27.5
South urban	672	21.3
Mother’s age in years, median (IQR)	3142	30 (25–34)
Mother’s age in years, %
≤19	178	5.6
20–24	596	18.9
25–29	775	24.6
≥ 30	1593	50.5
Missing	11	0.3
Parity, median (IQR)	3146	3 (2–5)
Parity, %
1	376	11.9
2–3	1304	41.4
∥ 4	1466	46.4
Missing	7	0.2
Known HIV-infected since:
Before index pregnancy	1593	50.5
During index pregnancy	1512	48.0
After index pregnancy	48	1.5
Spouse/cohabiting partner
Has partner	2882	91.4
No partner	265	8.4
Missing	6	0.2
Disclosure from mother to partnera
Mother disclosed	2696	93.5
Mother did not disclose	186	6.5
Disclosure from partner to mothera
Partner disclosed HIV status (any) to motherb	2107	73.1
Partner did not disclosec	774	26.8
Missing	1	0.0
Partner status reported by mothera
Partner is known HIV positive	1491	51.7
Partner is reported HIV negative	616	21.4
Partner’ HIV status unknown	774	26.9
Missing	1	0.0
Disclosure between partnersa
Both partners disclosed	2090	72.5
One partner disclosed	622	21.6
Neither of the partners disclosed	169	5.9
Missing	1	0.0
Maternal ART status
On ART	3053	96.8
Started but stopped ART	28	0.9
Unknown/did not want to reveal	44	1.4
Did not start ART	28	0.9
Number of days having missed ART in the last month among those on ART
0	2460	80.6
1 day	250	8.2
≥2 days	317	10.4
Missing	26	0.9
Infant nevirapine prophylaxis received
Yes, received any days from birth	3001	95.2
Missed nevirapine prophylaxis uptake	152	4.8
Exposed infants HIV status at 4–26 weeks (MTCT)
HIV-uninfected	3058	97.0
HIV-infected	95	3.0

HIV: human immunodeficiency virus

IQR: interquartile range

ART: antiretroviral therapy

MTCT: maternal-to-child transmission

^aAmong those with partner

^bMother reported knowing the result of partner’s HIV test if partner was ever tested

^cMother reported that partner never had an HIV test or did not know whether he had ever been tested